Barry Rosenstein Walgreens

Jana Partners Sees Transformation In Pharma; Targets JNPR

Jana Partners is making headlines again, this time for pressuring Juniper Networks, Inc. (NYSE:JNPR) with their shareholder activism, but not every relationship the group has with management teams is so adversarial. In fact, according to the latest performance update for the Jana Partners Master Fund, a copy of which was obtained by ValueWalk, there appears to be . . .


This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email and we will get back to you as quick as humanly possible

Saved Articles

Are you a smart investor? Join tens of thousands of sophisticated investor reading our authoritative free newsletter

* indicates required

Congrats! Are you a smart person?

We have an exclusive targeted for being a sophisticated and loyal reader.

Sign up today and get three months free

Use coupon code vip19 or click on the button below

Limited time offer only ENDS 9/130/2019 or after next 25 subscribers take advantage whichever comes first – please do not share this discount with others